feed,title,long_url,short_url
Benzinga,FDA Pushes Bristol Myers' Reblozyl Decision Date In Non-Transfusion Dependent Beta Thalassemia,https://benzinga.com/general/biotech/22/03/26295082/fda-pushes-bristol-myers-reblozyl-decision-date-in-non-transfusion-dependent-beta-thalassemia,https://bit.ly/3IBc4B3
Benzinga,Why Icosavax's Shares Are Trading Lower Today,https://benzinga.com/general/biotech/22/03/26294761/why-icosavaxs-shares-are-trading-lower-today,https://bit.ly/3tDVj3V
